ライフサイエンスコーパス: acute bronchitis

1 cin is no better than low-dose vitamin C for acute bronchitis.

2 ery low in primary care and in patients with acute bronchitis.

3 n and treatment of adults with uncomplicated acute bronchitis.

4 ing, cough, mucus production, sinusitis, and acute bronchitis.

5 2 weeks of clarithromycin co-medication for acute bronchitis.

6 ated with improved outcomes in patients with acute bronchitis?

7 the large majority of cases of uncomplicated acute bronchitis.2.

8 s were diagnosed in 71.9% (pneumonia, 42.3%; acute bronchitis, 21.9%; chronic obstructive pulmonary d

9 ctions (URTIs) (24%), acute sinusitis (24%), acute bronchitis (23%), otitis media (5%), pharyngitis,

10 ial AURI, including the common cold (53.4%), acute bronchitis (31.3%), acute sinusitis (13.6%), or ac

11 ominant mechanism of the bothersome cough of acute bronchitis.4.

12 (n = 42); asthma: 27 +/- 40 pg/ml (n = 11); acute bronchitis: 44 +/- 112 pg/ml (n = 14); pneumonia:

13 outine antibiotic treatment of uncomplicated acute bronchitis.6.

14 ration of cough in adults with uncomplicated acute bronchitis.7.

15 her causes of respiratory illnesses, such as acute bronchitis and upper respiratory tract infections,

16 ic URTIs, 53% with acute sinusitis, 62% with acute bronchitis, and 65% with otitis media.

17 specific upper respiratory tract infections, acute bronchitis, and influenza) from 18 months preinter

18 are for acute sinusitis, acute pharyngitis, acute bronchitis, and nonspecific upper respiratory trac

19 f appropriate antibiotic use for adults with acute bronchitis apply to immunocompetent adults without

20 ical incidence of influenza-like illness and acute bronchitis at that time.

21 In advanced disease, the incidence of acute bronchitis, bacterial pneumonia and P. carinii pne

22 mbers with entry CD4 counts < 200 cells/mm3, acute bronchitis, bacterial pneumonia, and P. carinii pn

23 and other respiratory infections (pneumonia, acute bronchitis) both during the same study period as w

24 studies suggest that antibiotic treatment of acute bronchitis can be reduced by using a combination o

25 of adults diagnosed as having uncomplicated acute bronchitis can be safely reduced using a combinati

26 RTI was identified using pneumonia codes and acute bronchitis codes.

27 fied upper respiratory tract infections, and acute bronchitis, conditions that are primarily viral.

28 Patient satisfaction with care for acute bronchitis depends most on physician-patient commu

29 Antibiotic prescriptions for uncomplicated acute bronchitis during baseline and study periods.

30 ific upper respiratory tract infections, and acute bronchitis (for which routine antibiotic treatment

31 Acute bronchitis is an acute cough illness in otherwise

32 outine antibiotic treatment of uncomplicated acute bronchitis is not recommended, regardless of durat

33 Whereas acute bronchitis is prevalent during all stages of HIV i

34 The value of azithromycin for treatment of acute bronchitis is unknown, even though this drug is co

35 e was also associated with decreased odds of acute bronchitis (OR = 0.23; 95%CI:0.22-0.23; p<0.001) o

36 e following Medical Subject Headings terms: "acute bronchitis," "respiratory tract infection," "phary

37 or a presumptive diagnosis of uncomplicated acute bronchitis should focus on ruling out serious illn

38 nts aged 18-64 years with an ARTI diagnosis (acute bronchitis, sinusitis, pharyngitis, otitis media,

39 Prescribing antibiotics for acute bronchitis was associated with reduced overall and

40 Acute bronchitis was the predominant lower respiratory i

41 ibiotic prescription rates for uncomplicated acute bronchitis were similar at all 4 sites during the

42 Adults diagnosed with acute bronchitis, without evidence of underlying lung di